HLA and kidney transplantation

Journal of Clinical Pathology

Volumn 63, Issue 1, 2010, Pages 21-25

  Clark, B ^a   Unsworth, D J ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN LYMPHOCYTE GLOBULIN; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; DACLIZUMAB; GLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; BONE MARROW SUPPRESSION; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; CHRONIC ALLOGRAFT NEPHROPATHY; COMPLEMENT DEPENDENT CYTOTOXICITY; DESENSITIZATION; DIABETOGENESIS; FLOW CYTOMETRY; GRAFT SURVIVAL; HLA MATCHING; HLA SYSTEM; HUMAN; HYPERACUTE GRAFT REJECTION; IMMUNOGENETICS; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LABORATORY DIAGNOSIS; LIVING DONOR; NEPHROTOXICITY; NEUROTOXICITY; OPPORTUNISTIC INFECTION; OSTEOPOROSIS; PANCREAS TRANSPLANTATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SCREENING; SIDE EFFECT; TREATMENT OUTCOME; TUBERCULOSIS;

DONOR SELECTION; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; TISSUE DONORS; TREATMENT OUTCOME;

EID: 74049160460     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.072785     Document Type: Review

References (20)

1. Nobel Foundation. Presentation speeches. nobelprize.org/nobel- prize/medicine/laureates/ (accessed 13 Nov 2009).
2. Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007;18:1046-56.
3. Paul LC, van Es LA, Riviere GB. Blood group B antigen on renal endothelium as a target for rejection in an ABO-incompatible recipient. Transplantation 1978;26:268-71.
4. Xuanming S, Zenios SA, Chakkera H, et al. Diminishing significance of HLA matching in kidney transplantation. Am J Trans 2004;4:1501-8.
5. Opelz G, Döhler B. Effect of HLA compatibility on kidney graft survival: comparative analysis of two decades. Transplantation 2007;84:137-43.
6. Frohn C, Fricke L, Puchta J, et al. The effect of HLA-C matching on acute renal allograft rejection. Nephrol Dial Transplant 2001;16:355-60.
7. Bushell A, Higgins RM, Wood KJ, et al. HLA-DQ mismatches between donor and recipient in the presence of HLA-DR compatibility do not influence the function or outcome of renal transplants. Hum Immunol 1989;26:179-89.
8. Laux G, Mansmann U, Deufel A, et al. A new epitope-based HLA-DPB matching approach for cadaver kidney transplants. Transplantation 2003;75:1527-32.
9. Lardy NM, van der Horst AR, ten Berge IJ, et al. Influence of HLA-DRB1* incompatibility on the occurrence of rejection episodes and graft survival in serologically HLA-DR-matched renal transplant combinations. Transplantation 1997;64:612-6.
10. Lougee E, Morjaria S, Shaw O, et al. Epityping-a new approach to the HLA system designed for solid organ transplantation. International Journal of Immunogenetics 2009;36:316.
11. Thaunat O, Hanf W, Dubois V, et al. Chronic humoral rejection mediated by anti-HLADP alloantibodies: insights into the role of epitope sharing in donor-specific and nondonor specific alloantibodies generation. Trans Immunol 2009;20:209-11.
12. Koo P, McKinley K, Newstead C, et al. Problems of donor compatibility in a patient with sensitization to an alternate allelic variant of a ''self'' allelic specificity. Nephrol Dial Transplant Plus. Published Online First: 2009. doi: 10.1093/ndtplus/ sfp151.
13. Idica A, Kaneku H, Everly MJ, et al. Elimination of post-transplant donor-specific HLA antibodies via bortezomib. Clin Transpl 2008:229-39.
14. Gupta A, Sinnott P. Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor. Hum Immunol 2009;70:618-22.
15. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969;280:735-9.
16. Taylor CJ, Kosmoliaptsis V, Summers DM, et al. Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation. Hum Immunol 2009;70:563-8.
17. Ravanan R, Dudley CR, Smith RM, et al. Use of skin grafting to demonstrate tolerance before kidney transplantation without immunosuppression in the recipient of a previous bone marrow transplant. Transplantation 2005;79:375-6.
18. Leichtman AB. Balancing efficacy and toxicity in kidney-transplant immunosuppression. N Engl J Med 2007;357:2625-7.
19. Vo AA, Lukovsky M, Toyoda M, et al. Rutiximab and intra-venous immune globulin for desensitization during renal transplantation. N Engl J Med 2008;359:242-51.
20. Higgins R, Hathaway M, Lowe D, et al. New choices for patients needing kidney transplantation across antibody barriers. J Ren Care 2008;34:85-93.